Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
natriumchlorid 0,9 % injektionsvæske, opløsning, ampul a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % injektionsvæske, opløsning, ampul a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 30 % infusionsvæske, koncentrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 600 IE (120 ¥ì) injektionsv©¡ske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Sodium chloride 50 mg/mL eye solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 9 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 1.500 IE (300 mkg) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
immunglobulin 1 g + natriumchlorid 0,9 % vægtvolumen injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
mepivacainhydrochlorid 30 mg + natriumklorid 3 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natrium + tolmetinnatrium 36 mg/492 mg kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natrium + tolmetinnatrium tablet 36 mg/492 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Product containing glucose and potassium chloride and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Product containing potassium chloride and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,18 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 1,8 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 2,7 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Product containing sodium benzoate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Product containing caffeine and sodium benzoate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Product containing sodium phenylacetate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
glucose 5 % i 0,2 % normalt saltvand |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,18 %/glucose 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 23,4 % injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % irrigationsvæske, aerosolspray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % injektionsvæske, opløsning, hætteglas a 6 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 23,4 % injektionsvæske, opløsning, pose a 250 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 23,4 % injektionsvæske, opløsning, pose a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % infusionsvæske, ampul a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % irrigationsvæske, 20 ml enkeltdosis |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % injektionsvæske, opløsning, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % irrigationsvæske i pose a 25 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % irrigationsvæske, pose a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
bakteriostatisk natriumchlorid 9 mg/ml (0,9 %) injektionsvæske, opløsning, hætteglas a 30 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 23,4 % injektionsvæske, opløsning, pose a 200 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,45 g/100 ml injektionsvæske, opløsning, hætteglas a 25 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % irrigationsvæske, flaske a 120 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % infusionsvæske, ampul a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % injektionsvæske, opløsning, hætteglas a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,45 g/100 ml injektionsvæske, opløsning, pose a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
bakteriostatisk natriumchlorid 9 mg/ml (0,9 %) injektionsvæske, opløsning, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 23,4 % injektionsvæske, opløsning, hætteglas a 30 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
bakteriostatisk natriumchlorid 9 mg/ml (0,9 %) injektionsvæske, opløsning, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
bakteriostatisk natriumchlorid 9 mg/ml (0,9 %) injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % injektionsvæske, opløsning, hætteglas a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % infusionsvæske, ampul a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % injektionsvæske, opløsning, hætteglas a 30 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,45 g/100 ml injektionsvæske, opløsning, pose a 1.000 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % injektionsvæske, opløsning, hætteglas a 25 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % injektionsvæske, opløsning, hætteglas a 2,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % infusionsvæske, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % infusionsvæske, ampul a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % injektionsvæske, opløsning, hætteglas a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,45 g/100 ml injektionsvæske, opløsning, pose a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 30 % injektionsvæske, koncentrat, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Sodium measurement, urine |
Component |
True |
Sodium electrolyte |
Inferred relationship |
Some |
1 |
24 hour urine sodium output measurement |
Component |
True |
Sodium electrolyte |
Inferred relationship |
Some |
1 |